In a trinitrobenzene sulfonic acid-induced IBD model, which mimics the pathology of human CD, administration of recombinant IL-33 (rIL-33) into mice ameliorated colonic tissue injury and clinical symptoms (156). The gene discussed is IL33; the disease is inflammatory bowel disease.